JAMA Theme Issue Media Briefing New York, NY [email protected].

24
JAMA Theme Issue Media Briefing JAMA Theme Issue Media Briefing New York, NY [email protected]

Transcript of JAMA Theme Issue Media Briefing New York, NY [email protected].

Page 1: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

JAMA Theme Issue Media BriefingJAMA Theme Issue Media BriefingNew York, NY

[email protected]

Page 2: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

In the U.S., severe obesity is rapidly increasing at a rate greater than moderate obesity

There are a projected 31 million Americans meeting criteria for bariatric surgery

Long-term studies relating the health benefits of gastric bypass surgery remain limited

Page 3: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Prospectively compare clinical outcomes in severely obese patients receiving RYGB surgery with similarly severely obese controls

See bariatric surgery types on JAMA’s Patient Page (page 1173) - banding not approved in US and the sleeve not performed when Utah study initiated

Page 4: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

315

387

388

Exam 3

319

410

400

Exam 2

Utah Obesity Study DesignUtah Obesity Study Design

Exam 1

2 Years 6 Years

321

Utah Health Family Tree

Program

Baseline

417

No Surgery

418

RYGBSurgical Center

Page 5: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Type 2 diabetes: Fasting blood glucose ≥ 126 mg/dL, HgA1c ≥ 6.5% or antidiabetic medication

Dyslipidemia: Fasting LDL-C ≥ 160 mg/dL, fasting HDL-C < 40 mg/dL, or fasting triglycerides ≥ 200 mg/dL or using lipid lowering medication

Hypertension: Resting clinic blood pressure ≥ 140/90 mmHg or antihypertensive medication

Quality of Life (QOL): Obesity-specific QOL tool and SF-36 (physical and mental)

Page 6: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Propensity scores – this analysis adjusts for differences in groups

Logistic regression – this analysis adjusts for any remaining differences

Remission of baseline prevalent disease defined as clinically normal levels of fasting glucose and lipids and of resting blood pressure – each without reported medication use at examination three

Page 7: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

VariablesRYGB

Surgery (418)

Control Group 1

(417)

Control Group 2

(321)

Female, % 84.4 84.4 76.0*

Age, y 42.5 43.0 49.4*

BMI 47.3 46.3 43.8*

SBP, mm Hg 126.3 125.6 128.8

DBP, mm Hg 71.9 72.0 72.3

Glucose, mg/dL 101 107* 107*

Quality of life 31.4 34.9* 54.4*

* Statistical difference between groups

Page 8: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

%

Surgery Group Control Group 1 Control Group 2

Page 9: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

mg

/dL

Surgery Group Control Group 1 Control Group 2

Page 10: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

mg

/dL

Surgery Group Control Group 1 Control Group 2

Page 11: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

mg

/dL

Surgery Group Control Group 1 Control Group 2

Page 12: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Only surgical patients

Percent Weight Change

Page 13: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Percent Weight Change

Page 14: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

At 6 years:

96% of the RYGB group had maintained more than 10% of weight loss from baseline

76% had maintained more than 20% weight loss from baseline

Page 15: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

At 6 years, RYGB had:

Decrease in fasting glucose of 23.7 mg/dL relative to control group 1

Decrease of 19.5 mg/dL relative to control group 2

Page 16: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

GroupBaseline

PrevalenceIncidence Remission

Surgery 22% 2% 62%

Control 1 25% 17% 8%

Control 2 29% 15% 6%

OR: 0.11

OR: 0.21

OR: 16.5

OR: 21.5

Page 17: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

GroupBaseline

PrevalenceIncidence Remission

Surgery 43% 16% 42%

Control 1 43% 31% 18%

Control 2 52% 33% 9%

OR: 0.40

OR: 0.47

OR: 2.9

OR: 5.0

Page 18: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

GroupBaseline

PrevalenceIncidence Remission

Surgery 20% 4% 53%

Control 1 18% 25% 22%

Control 2 21% 30% 10%

OR: 0.12

OR: 0.14

OR: 4.4

OR: 6.8

Page 19: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

GroupBaseline

PrevalenceIncidence Remission

Surgery 41% 5% 67%

Control 1 45% 32% 34%

Control 2 36% 38% 18%

OR: 0.10

OR: 0.10

OR: 3.8

OR: 6.2

Page 20: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Group Baseline Prevalence

Incidence Remission

Surgery 43% 3% 71%

Control 1 41% 25% 33%

Control 2 41% 28% 34%

OR: 0.10

OR: 0.13

OR: 5.1

OR: 3.4

Page 21: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

RYGB surgery provided long-term diabetes, hypertension, and abnormal lipid remission and improvement in other risk factors when compared with severely obese patients not having surgery

There was a 5- to 9-fold reduction in the risk of new diabetes in surgical patients compared with severely obese controls who did not have surgery

The large improvement in fasting glucose seen at 2 years follow-up, continued to 6 years

Significant weight loss was sustained for an average of 6 years

Page 22: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Available at www.jama.com

TD Adams and coauthors

Health Benefits of Gastric Bypass Surgery After 6 Years

Page 23: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.
Page 24: JAMA Theme Issue Media Briefing New York, NY ted.adams@utah.edu.

Category BMI Female Male

Normal weight 18.5 - 25 140 lb 166 lb

Overweight 25 - 30 176 lb 203 lb

Obese Class I (moderately obese)

30 - 35 208 lb 240 lb

Obese Class II (severely obese)

35 - 40 239 lb 277 lb

Obese Class III (very severely obese)

> 40 300 lb 347 lb

(67 in) (72 in)